Estimating individual lifetime benefit and bleeding risk with NOAC addition to asprin in stable CVD

5' education - Oct. 14, 2019 - Paris, France - Tamar de Vries, MD – Utrecht, The Netherlands

Educational information

In the Cardiovascular Scene Investigation (CSI) series, investigators from Utrecht report at the ESC congress, from the perspective of young investigators. They put a question to researchers about presented study results.

Faculty

Tamar de Vries, MD – PhD candidate, UMC Utrecht, The Netherlands

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.

Click here to go to U-prevent

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.